ArticleslgStudy

chemistry

Thiotepa

Thiotepa is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Thiotepa rather than just read about it. In short: Thiotepa (N,N',N''(-triethylenethiophosphoramide, INN), sold under the brand name Tepadina among others, is an anti-cancer medication. Thiotepa is an organophosphorus compound with the formula (C2H4N)3PS.

Thiotepa — main illustration
Thiotepa — illustration

Key takeaways

  • Thiotepa belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Thiotepa to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Thiotepa from memory before moving on to harder problems.

Reference excerpt

Thiotepa (N,N',N''(-triethylenethiophosphoramide, INN), sold under the brand name Tepadina among others, is an anti-cancer medication. Thiotepa is an organophosphorus compound with the formula (C2H4N)3PS.

History Thiotepa and its synthesis were patented in 1952 by the American Cyanamid company. It was made for use in the textile industry and in the production process of plastics. However, thiotepa entered human trials in 1953 and was found to be effective against acute myeloid leukemia, chronic myelogenous leukemia, and Hodgkin's lymphoma. The first clinical trial noted a "reasonable margin for safety" between the apparent dose and undesired bone marrow suppression In January 2007, the European Medicines Agency (EMA) designated thiotepa as an orphan drug. In April 2007, the United States FDA designated thiotepa as a conditioning treatment for use prior to hematopoietic stem cell transplantation. In June 2024, the FDA approved a ready-to-dilute liquid formulation of thiotepa to treat breast and ovarian cancer.

Structure Thiotepa consists of three aziridine rings (also known as ethylenimines), which are cyclic compounds containing two carbon atoms and one nitrogen atom, all bonded to a phosphine sulfide group. The phosphine sulfide acts as an activating group, activating the aziridine groups.

Reactivity Thiotepa is a reactive compound that, under acidic, neutral, or alkaline conditions, undergoes solvolysis, leading to potential side reactions such as polymerization and dimerization into piperazines. During acidic degradation, thiotepa reacts with chloride ions to produce monochloro, dichloro, and trichloro derivatives. Acidic conditions also result in the formation of tepa (N,N′,N″-triethylenephosphoramide), the first identified and more reactive metabolite of thiotepa. In alkaline media, thiotepa undergoes degradation, though no detectable byproducts were identified. Like other aziridine-containing compounds, hydroxyl substitution reactions may release aziridine. This degradation pathway has also been reported for tepa. The stability of thiotepa in biological samples is dependent on pH. In plasma, the monochloro derivative of thiotepa is formed, while in urine, both monochloro and dichloro derivatives have been found. Thiotepa is most stable between pH 7 and 11. In plasma under physiological conditions, the compound has a half-life of five days, whereas in urine at 37 °C, the half-life is 16 minutes at pH 4 and 21 hours at pH 6.

Synthesis Two separate syntheses of thiotepa have been described in literature. The most prevalent method involves the addition of an excess of aziridine to thiophosphoryl chloride in the presence of a base such as triethylamine (TEA) (or another molar equivalent of aziridine) and a suitable solvent (e.g., ether or benzene). The first molecule of aziridine reacts with thiophosphoryl chloride to produce dichloridophosphorothionate, which is sufficiently reactive due to the poor overlap of the nitrogen lone pair with the P=S bond, allowing it to react with another two molecules of aziridine

Thiotepa has also been synthesized from phosphorus trichloride and six molar equivalents of aziridine. The trivalent triamide formed reacts with octasulfur (S8) in benzene.

Medical uses Thiotepa is used in combination with other chemotherapy agents to treat cancer. It can be given with or without total body irradiation (TBI) to prepare the body for allogeneic or autologous hematopoietic progenitor cell transplantation (HPCT), which replaces damaged blood-forming cells with donor cells. This treatment is used in both adults and children for blood cancers such as Hodgkin lymphoma and leukemia. Thiotepa is also used with high-dose chemotherapy and HPCT support to treat certain solid tumors in adults and children. Thiotepa is used in palliative care for several types of cancer, including breast cancer, ovarian cancer, papillary thyroid cancer, and bladder cancer. It is also used to control intracavitary effusions caused by serosal neoplastic deposits, which refers to fluid buildup resulting from cancer spreading to the lining of body cavities. In Japan, a widely used regimen consisting of high-dose thiotepa and melphalan, followed by autologous peripheral blood stem cell rescue, is used to treat high-risk neuroblastoma.

Administration Thiotepa is mainly administered intravenously and intravesically. The administered dose regarding different types of cancer variates between 3 mg/kg/day to 13 mg/kg/day. Thiotepa is unreliably absorbed from the gastrointestinal tract: acid instability prevents thiotepa from being administered orally. Thiotepa is also used in the treatment of bladder cancer during this treatment thiotepa is used as intravesical chemotherapy. Thiotepa is frequently administered in combination with other chemotherapeutic agents such as busulfan and carboplatin.

Clinical outcomes In clinical trials the outcome of different types of treatment is compared to identify if a compound or regimen is favourable for the patient. The choice of treatment in the conditioning therapy can have a profound impact on progression-free survival (PNS), overall survival (OS), relapse incidence (RI) and non-relapse mortality (NRM). The studies mentioned summarize key findings comparing various conditioning regimens. Studies on conditioning regimens for hematopoietic cell transplant in primary central nervous system lymphoma (PCNSL) have shown that thiotepa based therapies thiotepa/busulfan/cyclophosphamide (TBC) and thiotepa/carmustine (TT-BCNU) improve progression-free survival of PCNSL compared to traditional therapies carmustine/etoposide/cytarabine/melphalan (BEAM). Research also suggests that in BEAM if carmustine is exchanged for thiotepa no statistical difference was found in PFS, OS and RI. Furthermore, the capacity of thiotepa to pass the blood-brain barrier may allow optimizing the therapy for patients with Central Nervous System involvement of increased CNS relapse risk. Another study compared total body irradiation (TBI) and thiotepa, busulfan and cyclophosphamide/fludarabine (TTB) as a conditioning regiment of patients with acute lymphoblastic leukemia undergoing allogenic hematopoietic stem cell transplantation. No statistical difference was found in the overall survival but the RI was higher in the TBI regimen but the NRM was lower with TTB suggesting that TBB might be a viable alternative to TBI.

Metabolism

… excerpt ends here. Continue reading the full article.

Illustrations

Thiotepa illustration
Thiotepa illustration
Thiotepa: Thiotepa synthesis via thiophosphoryl chloride and aziridine
Thiotepa synthesis via thiophosphoryl chloride and aziridine
Thiotepa: Biotransformation of thiotepa, (a) thiotepa, (b) tepa, (c) monochlorotepa, (d) GSH conjugate of thioTEPA, (e) thiotepacysteinate, (f) thiotepa-mercapturate.
Biotransformation of thiotepa, (a) thiotepa, (b) tepa, (c) monochlorotepa, (d) GSH conjugate of thioTEPA, (e) thiotepacysteinate, (f) thiotepa-mercapturate.
Thiotepa: Mechanism of alkylation by thiotepa. a): Alkylation of DNA via the N-7 position of guanine. b): General mechanism forming monoalkylated and cross-linked DNA.
Mechanism of alkylation by thiotepa. a): Alkylation of DNA via the N-7 position of guanine. b): General mechanism forming monoalkylated and cross-linked DNA.

Worked examples

Example 1 — a first encounter with Thiotepa

Start with the simplest possible case. Write down what Thiotepa claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Thiotepa before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Thiotepa ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Thiotepa

In research
Thiotepa appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Thiotepa in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Thiotepa is common in secondary-school and first-year university syllabi. It links to neighbouring topics 1-Aziridinyl compounds, Alkylating antineoplastic agents, CYP2B6 inhibitors, so understanding it makes those chapters shorter.
In everyday life
Look for Thiotepa outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Thiotepa in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Thiotepa means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Thiotepa out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Thiotepa in simple terms?

Thiotepa (N,N',N''(-triethylenethiophosphoramide, INN), sold under the brand name Tepadina among others, is an anti-cancer medication. Thiotepa is an organophosphorus compound with the formula (C2H4N)3PS.

Why does Thiotepa matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Thiotepa?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Thiotepa.

Tags

  • 1-Aziridinyl compounds
  • Alkylating antineoplastic agents
  • CYP2B6 inhibitors
  • Cancer treatments
  • IARC Group 1 carcinogens
  • Organophosphoric amides
  • Orphan drugs
  • Thiophosphoryl compounds

Keep exploring